Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer by Daniele Lavacchi, Sara Fancelli, Sara Fancelli, Giandomenico Roviello, Francesca Castiglione, Enrico Caliman, Enrico Caliman, Gemma Rossi, Jacopo Venturini, Elisa Pellegrini, Marco Brugia, Agnese Vannini, Caterina Bartoli, Fabio Cianchi, Serena Pillozzi, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo

Get full text

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine by Francesco Di Costanzo, Federica Di Costanzo, Lorenzo Antonuzzo, Ernesto Mazza, Elisa Giommoni

Get full text

KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients by Daniele Lavacchi, Simone Polvani, Antonio Taddei, Antonio Taddei, Federico Scolari, Luca Messerini, Enrico Caliman, Luca Moraldi, Alessia Guidolin, Gian Luca Grazi, Andrea Galli, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo

Get full text

Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level by Serena Pillozzi, Andrea Bernini, Ilaria Palchetti, Olivia Crociani, Lorenzo Antonuzzo, Domenico Campanacci, Guido Scoccianti

Get full text

KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real... by Sara Fancelli, Sara Fancelli, Enrico Caliman, Enrico Caliman, Francesca Mazzoni, Luca Paglialunga, Marta Rita Gatta Michelet, Daniele Lavacchi, Rossana Berardi, Giulia Mentrasti, Giulio Metro, Ilaria Birocchi, Angelo Delmonte, Ilaria Priano, Camilla Eva Comin, Camilla Eva Comin, Francesca Castiglione, Caterina Bartoli, Luca Voltolini, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo, Lorenzo Antonuzzo, Lorenzo Antonuzzo

Get full text

Pembrolizumab-associated anti-MDA5 dermatomyositis in a patient with lung cancer: a first case report by Antonino Marcello Pilia, Lorenzo Salvati, Alessia Guidolin, Francesca Mazzoni, Lorenzo Antonuzzo, Paola Parronchi, Francesco Liotta

Get full text

Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment by Lorenzo Antonuzzo, Sara Fancelli, Maria Cristina Petrella, Elisabetta Gambale, Enrico Caliman, Laura Doni, Serena Pillozzi

Get full text

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives by Sara Fancelli, Enrico Caliman, Francesca Mazzoni, Marco Brugia, Francesca Castiglione, Luca Voltolini, Serena Pillozzi, Lorenzo Antonuzzo

Get full text

Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma—A Prosp... by Stefano Bongiolatti, Francesca Mazzoni, Ottavia Salimbene, Enrico Caliman, Carlo Ammatuna, Camilla E. Comin, Lorenzo Antonuzzo, Luca Voltolini

Get full text

Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience by Daniele Lavacchi, Giandomenico Roviello, Elisa Giommoni, Lorenzo Dreoni, Silvia Derio, Marco Brugia, Amedeo Amedei, Serena Pillozzi, Lorenzo Antonuzzo

Get full text

Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors by Giandomenico Roviello, Martina Catalano, Ugo De Giorgi, Marco Maruzzo, Sebastiano Buti, Sebastiano Buti, Elisabetta Gambale, Giuseppe Procopio, Carlotta Ottanelli, Enrico Caliman, Enrico Caliman, Luca Isella, Pierangela Sepe, Nicole Brighi, Matteo Santoni, Luca Galli, Raffaele Conca, Laura Doni, Lorenzo Antonuzzo, Lorenzo Antonuzzo

Get full text

Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study by Agnese Paderi, Sara Fancelli, Enrico Caliman, Serena Pillozzi, Elisabetta Gambale, Marinella Micol Mela, Laura Doni, Francesca Mazzoni, Lorenzo Antonuzzo

Get full text

Pharmacogenomics of soft tissue sarcomas: New horizons to understand efficacy and toxicity by Elisabetta Gambale, Anna Boddi, Adriano Pasqui, Domenico Andrea Campanacci, Guido Scoccianti, Ilaria Palchetti, Andrea Bernini, Lorenzo Antonuzzo, Serena Pillozzi

Get full text

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors by Agnese Paderi, Roberta Giorgione, Elisa Giommoni, Marinella Micol Mela, Virginia Rossi, Laura Doni, Andrea Minervini, Marco Carini, Serena Pillozzi, Lorenzo Antonuzzo

Get full text

Targeting KCa3.1 channels to overcome erlotinib resistance in non-small cell lung cancer cells by Luca Matteo Todesca, Matthias Gerke, Emma Etmar Bulk, Magdalena Bachmann, Alisa Rudersdorf, Lorenzo Antonuzzo, Serena Pillozzi, Martina Düfer, Ildiko Szabo, Albrecht Schwab

Get full text

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective by Daniele Lavacchi, Elisa Pellegrini, Valeria Emma Palmieri, Laura Doni, Marinella Micol Mela, Fabrizio Di Maida, Amedeo Amedei, Serena Pillozzi, Marco Carini, Lorenzo Antonuzzo

Get full text

Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer by Daniele Lavacchi, Giandomenico Roviello, Alessia Guidolin, Silvia Romano, Jacopo Venturini, Enrico Caliman, Agnese Vannini, Elisa Giommoni, Elisa Pellegrini, Marco Brugia, Serena Pillozzi, Lorenzo Antonuzzo

Get full text

A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy by Jasminka Hasic Telalovic, Serena Pillozzi, Rachele Fabbri, Alice Laffi, Daniele Lavacchi, Virginia Rossi, Lorenzo Dreoni, Francesca Spada, Nicola Fazio, Amedeo Amedei, Ernesto Iadanza, Lorenzo Antonuzzo

Get full text

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated – NIVACOR trial (GOIRC... by Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo, Guglielmo Nasti, Francesca Bergamo, Roberto Bordonaro, Evaristo Maiello, Alberto Zaniboni, Giuseppe Tonini, Alessandra Romagnani, Annalisa Berselli, Nicola Normanno, Carmine Pinto

Get full text

Eosinophil Count as Predictive Biomarker of Immune-Related Adverse Events (irAEs) in Immune Checkpoint Inhibitors (ICIs) Therapies in Oncological Patients by Elisa Giommoni, Roberta Giorgione, Agnese Paderi, Elisa Pellegrini, Elisabetta Gambale, Andrea Marini, Andrea Antonuzzo, Riccardo Marconcini, Giandomenico Roviello, Marco Matucci-Cerinic, David Capaccioli, Serena Pillozzi, Lorenzo Antonuzzo

Get full text